Your browser doesn't support javascript.
loading
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.
Chari, Ajai; Krishnan, Amrita; Rasche, Leo; Ye, Jing Christine; Garfall, Alfred; Popat, Rakesh; Lipe, Brea; Qin, Xiang; Campagna, Michela; Masterson, Tara; Tomlinson, Chalmer; Hilder, Brandi; Tolbert, Jaszianne; Renaud, Thomas; Smit, M Damiette; Gray, Kathleen; Kane, Colleen; Heuck, Christoph; van de Donk, Niels W C J.
Affiliation
  • Chari A; Department of Medicine, Hematology, and Medical Oncology and Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY. Electronic address: ajai.chari@ucsf.edu.
  • Krishnan A; Judy and Bernard Briskin Myeloma Center, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Rasche L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Ye JC; Department of Lymphoma - Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center, University of Texas, Houston, TX.
  • Garfall A; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Popat R; Hematology Department, University College London Hospitals NHS Foundation Trust, London, UK.
  • Lipe B; Department of Medicine, University of Rochester Medical Center, Rochester, NY.
  • Qin X; Janssen Research and Development, Spring House, PA.
  • Campagna M; Janssen Research and Development, Madrid, Spain.
  • Masterson T; Janssen Research and Development, Spring House, PA.
  • Tomlinson C; Janssen Research and Development, Raritan, NJ.
  • Hilder B; Janssen Research and Development, Spring House, PA.
  • Tolbert J; Janssen Research and Development, Spring House, PA.
  • Renaud T; Janssen Research and Development, Raritan, NJ.
  • Smit MD; Janssen Biologics B.V., Leiden, The Netherlands.
  • Gray K; Janssen Scientific Affairs, Horsham, PA.
  • Kane C; Janssen Research and Development, Spring House, PA.
  • Heuck C; Janssen Research and Development, Spring House, PA.
  • van de Donk NWCJ; Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Clin Lymphoma Myeloma Leuk ; 2024 May 15.
Article de En | MEDLINE | ID: mdl-38871558
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Clin Lymphoma Myeloma Leuk Sujet du journal: NEOPLASIAS Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Clin Lymphoma Myeloma Leuk Sujet du journal: NEOPLASIAS Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique